Effect of acetazolamide on acute mountain sickness.
D000086:Acetazolamide / Q000494:pharmacology / Q000627:therapeutic use*; D000208:Acute Disease; D000328:Adult; D000471:Alkalosis / Q000517:prevention & control; D000531:Altitude; D001639:Bicarbonates / Q000097:blood; D001769:Blood; D001794:Blood Pressure; D002245:Carbon Dioxide / Q000097:blood; D002986:Clinical Trials as Topic; D005767:Gastrointestinal Diseases / Q000209:etiology; D006261:Headache / Q000209:etiology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006985:Hyperventilation; D000860:Hypoxia / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D010100:Oxygen / Q000097:blood; D010919:Placebos; D011650:Pulmonary Alveoli; D012119:Respiration; D007319:Sleep Initiation and Maintenance Disorders / Q000209:etiology; D013147:Spirometry
D001639:Bicarbonates; D010919:Placebos; D002245:Carbon Dioxide; D000086:Acetazolamide; D010100:Oxygen